About Jessica Childs-Disney
Form D filings for Ribonaut Therapeutics in 2023 list Jessica Childs-Disney as promoter.
Jessica Childs-Disney first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jessica Childs-Disney in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jessica Childs-Disney works with at each company, as listed on that company's latest Form D.
Ribonaut Therapeutics, Inc. · Form D, Jan 4, 2023
ZC
Zachary Collins
Executive officer
ST
Steven Tregay
Director
MD
Matthew Disney
Executive officer and director
LL
Lusong Luo
Director